curevac - dofaq.co
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights
Reuters - 25 Apr 2024
Acuitas, CureVac settle lawsuit over COVID-19 vaccine patent rights ...
CureVac Names New Chief Business Officer
Contract Pharma - 24 Apr 2024
CureVac Names New Chief Business Officer ...
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines
MD Anderson Cancer Center - 16 Apr 2024
MD Anderson and CureVac enter strategic collaboration to develop novel cancer vaccines ...
CureVac initiates H5N1 avian influenza vaccine study
Clinical Trials Arena - 25 Apr 2024
CureVac initiates H5N1 avian influenza vaccine study ...
Biopharma Layoff Tracker 2024: BMS, CureVac, Tessera and More Cut Staff
BioSpace - 26 Apr 2024
Biopharma Layoff Tracker 2024: BMS, CureVac, Tessera and More Cut Staff ...
Acuitas, Partner CureVac Settle Clash Over Vaccine-Tech Patents
Bloomberg Law - 26 Apr 2024
Acuitas, Partner CureVac Settle Clash Over Vaccine-Tech Patents ...
CureVac Shares Touch All-Time Low After Germany Deal Ends, Redesign News
MarketWatch - 24 Apr 2024
CureVac Shares Touch All-Time Low After Germany Deal Ends, Redesign News ...
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
Investing.com India - 18 Apr 2024
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024 ...
CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines - PharmaTimes
PharmaTimes - 19 Apr 2024
CureVac and MD Anderson Cancer Center partner to develop new cancer vaccines - PharmaTimes ...
CureVac, chasing Moderna mRNA flu shot, hits similar problems
Fierce Biotech - 04 Apr 2024
CureVac, chasing Moderna mRNA flu shot, hits similar problems ...
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
Yahoo Finance - 24 Apr 2024
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update ...
German Federal Patent Court changes its mind on CureVac mRNA patent
JUVE Patent - 19 Dec 2023
German Federal Patent Court changes its mind on CureVac mRNA patent ...
CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma
CureVac - 20 Jun 2023
CureVac Doses First Patient in Phase 1 Study of Cancer Vaccine Candidate for Surgically Resected Glioblastoma ...
CureVac announces positive Phase II Covid-19 vaccine trial data
Clinical Trials Arena - 09 Jan 2024
CureVac announces positive Phase II Covid-19 vaccine trial data ...
CureVac, MD Anderson Enter Strategic Cancer Vax Pact
Contract Pharma - 16 Apr 2024
CureVac, MD Anderson Enter Strategic Cancer Vax Pact ...
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
Yahoo Finance - 24 Apr 2024
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer ...
Xaira, Anthos, CureVac & more—Chutes & Ladders
Fierce Biotech - 26 Apr 2024
Xaira, Anthos, CureVac & more—Chutes & Ladders ...
CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech
CureVac - 19 May 2023
CureVac Announces Developments in Patent Litigation with Pfizer/BioNTech ...
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with ...
Yahoo Finance - 24 Apr 2024
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with ... ...